ARCHIVES

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

This article is from The Cancer Letter archive.

Vol. 24 No. 16 | April 24, 1998

Download PDF Visit The Full Archive

Related Articles

NCI 1985 Bypass Budget By Groups

May 20, 1983

Bayh To Receive ACCC Annual Award

February 8, 1980

New Model Provides Better Estimate of Breast Cancer Risk in Black Women.

November 30, 2007

FDA Moves to Regulate Lab-Developed Tests

August 1, 2014

Lymphedema Education Helps Reduce Symptoms, Study Finds

August 28, 2009

Crout Resigns As Director Of FDA Drugs Bureau

July 11, 1980